R. M. Bremnes

420 total citations
15 papers, 308 citations indexed

About

R. M. Bremnes is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Epidemiology. According to data from OpenAlex, R. M. Bremnes has authored 15 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Cancer Research and 3 papers in Epidemiology. Recurrent topics in R. M. Bremnes's work include Testicular diseases and treatments (2 papers), Brain Metastases and Treatment (2 papers) and Cancer Genomics and Diagnostics (2 papers). R. M. Bremnes is often cited by papers focused on Testicular diseases and treatments (2 papers), Brain Metastases and Treatment (2 papers) and Cancer Genomics and Diagnostics (2 papers). R. M. Bremnes collaborates with scholars based in Norway, Sweden and United Kingdom. R. M. Bremnes's co-authors include Marianne Brydøy, Jan‐Magnus Kvamme, Ulf Aasebø, E. Wist, E Jacobsen, Helge Stalsberg, S. D. Fosså, Tore Wentzel‐Larsen, Erik R. Hauge and Jan Oldenburg and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and British Journal of Cancer.

In The Last Decade

R. M. Bremnes

13 papers receiving 289 citations

Peers

R. M. Bremnes
R Curík Czechia
M. J. Merino United States
Adnan Yöney Türkiye
Kyu-Rae Kim South Korea
Neil Fenn United Kingdom
Maryam Kadivar Iran
Marin Nola Croatia
Kou Kaneko Japan
Diane Kenwright New Zealand
Andrea Wahner Hendrickson United States
R Curík Czechia
R. M. Bremnes
Citations per year, relative to R. M. Bremnes R. M. Bremnes (= 1×) peers R Curík

Countries citing papers authored by R. M. Bremnes

Since Specialization
Citations

This map shows the geographic impact of R. M. Bremnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. M. Bremnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. M. Bremnes more than expected).

Fields of papers citing papers by R. M. Bremnes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. M. Bremnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. M. Bremnes. The network helps show where R. M. Bremnes may publish in the future.

Co-authorship network of co-authors of R. M. Bremnes

This figure shows the co-authorship network connecting the top 25 collaborators of R. M. Bremnes. A scholar is included among the top collaborators of R. M. Bremnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. M. Bremnes. R. M. Bremnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Haugnes, Hege Sagstuen, Torgeir Wethal, Nina Aass, et al.. (2010). Cardiovascular risk in long-term testicular cancer survivors.. Journal of Clinical Oncology. 28(15_suppl). 4533–4533. 1 indexed citations
3.
Sanmartín, Elena, Eloísa Jantus‐Lewintre, Ana Blasco, et al.. (2010). Plasma levels of VEGF-A and VEGFR-2 in advanced NSCLC.. Journal of Clinical Oncology. 28(15_suppl). 10623–10623. 2 indexed citations
4.
Brydøy, Marianne, Jan Oldenburg, O. Klepp, et al.. (2009). Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer Survivors. JNCI Journal of the National Cancer Institute. 101(24). 1682–1695. 111 indexed citations
5.
Tandstad, Torgrim, Gabriella Cohn‐Cedermark, Eva Cavallin‐Ståhl, et al.. (2008). Risk-adapted treatment in clinical stage 1 (CS1), non-seminomatous germ cell testicular cancer (NSGCT). Journal of Clinical Oncology. 26(15_suppl). 5034–5034. 4 indexed citations
6.
Al‐Shibli, Khalid, et al.. (2008). The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. European Journal of Cancer Supplements. 6(9). 163–163. 2 indexed citations
7.
Plessen, Christian von, Bengt Bergman, R. M. Bremnes, et al.. (2006). Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer. British Journal of Cancer. 95(8). 966–973. 124 indexed citations
8.
Brydøy, Marianne, Jan Oldenburg, Olbjørn Klepp, et al.. (2006). Self-reported paresthesias, Raynaud’s phenomena, tinnitus, and hearing impairment in a large cohort of long-term testicular cancer (TC) survivors. Journal of Clinical Oncology. 24(18_suppl). 4547–4547. 2 indexed citations
9.
Sirera, Rafael, Carlos Camps, Lola Llobat, et al.. (2006). The quantification of the catalytic subunit of telomerase in plasma is a prognostic factor in advanced non-small cell lung cancer (NSCLC) patients. Journal of Clinical Oncology. 24(18_suppl). 7052–7052. 1 indexed citations
10.
Sirera, Rafael, Carlos Camps, R. M. Bremnes, et al.. (2005). PD-026 The analysis of serum DNA concentration by means of hTERT quantification: A useful prognostic factor in advanced non-small cell lung cancer (NSCLC). Lung Cancer. 49. S74–S74. 2 indexed citations
11.
Berrocal, Alfonso, Rafael Sirera, Carlos Camps, et al.. (2005). The quantification of DNA in the serum is a useful prognostic factor in advanced non-small cell lung cancer (NSCLC) patients. Journal of Clinical Oncology. 23(16_suppl). 7195–7195. 1 indexed citations
12.
Bremnes, R. M., Jan‐Magnus Kvamme, Helge Stalsberg, & E Jacobsen. (1999). Pilomatrix carcinoma with multiple metastases: report of a case and review of the literature. European Journal of Cancer. 35(3). 433–437. 51 indexed citations
13.
Aasebø, Ulf & R. M. Bremnes. (1998). [Is treatment of lung cancer characterized by nihilism?].. PubMed. 118(13). 2056–2056. 1 indexed citations
14.
Bremnes, R. M.. (1994). PITUITARY-GONADAL DYSFUNCTION IN MALE PATIENTS WITH LUNG CANCER. 1 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by R Curík Breakdown of academic impact, for papers by M. J. Merino Breakdown of academic impact, for papers by Adnan Yöney Breakdown of academic impact, for papers by Kyu-Rae Kim Breakdown of academic impact, for papers by Neil Fenn Breakdown of academic impact, for papers by Maryam Kadivar Breakdown of academic impact, for papers by Marin Nola Breakdown of academic impact, for papers by Kou Kaneko Breakdown of academic impact, for papers by Diane Kenwright Breakdown of academic impact, for papers by Andrea Wahner Hendrickson
Rankless by CCL
2026